ConductScience.org, home

Paper18620522

Downregulating sphingosine kinase-1 for cancer therapy.

Cuvillier O. Expert Opin Ther Targets, 2008. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Downregulating sphingosine kinase-1 for cancer therapy. Papers, record 18620522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18620522

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Downregulating sphingosine kinase-1 for cancer therapy.
PubMed
Journal
Expert Opin Ther Targets
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.32
iCite
Revised in PubMed
2026-01-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cuvillier OOlivier

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Phosphotransferases (Alcohol Group Acceptor)Major topic
Down-Regulation
Humans
Up-Regulation
Sphingosine Kinase

Source PubMed

Download CSV of topics

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
40006080Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40006080PubMed
39720352Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications.Noncoding RNA Res2025https://conductscience.org/library/papers/39720352PubMed
39148542Naringin and temozolomide combination suppressed the growth of glioblastoma cells by promoting cell apoptosis: network pharmacology, in-vitro assays and metabolomics based study.Front Pharmacol2024https://conductscience.org/library/papers/39148542PubMed
39114142Nanoparticle co-delivery of carboplatin and PF543 restores platinum sensitivity in ovarian cancer models through inhibiting platinum-induced pro-survival pathway activation.Nanoscale Adv2024https://conductscience.org/library/papers/39114142PubMed
37779595Integrative roles of sphingosine kinase in liver pathophysiology.Toxicol Res2023https://conductscience.org/library/papers/37779595PubMed
34737701Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases.Front Pharmacol2021https://conductscience.org/library/papers/34737701PubMed
33317322The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.Cancer Control2020https://conductscience.org/library/papers/33317322PubMed
31998289Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies.Front Immunol2019https://conductscience.org/library/papers/31998289PubMed
31423186Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine.Oncol Lett2019https://conductscience.org/library/papers/31423186PubMed
30043096Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.Breast Cancer Res Treat2018https://conductscience.org/library/papers/30043096PubMed
27581969Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells.BMC Cancer2016https://conductscience.org/library/papers/27581969PubMed
27036015The emerging role of FTY720 (Fingolimod) in cancer treatment.Oncotarget2016https://conductscience.org/library/papers/27036015PubMed
26974204Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer.Oncogenesis2016https://conductscience.org/library/papers/26974204PubMed
26472207Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.Neurotox Res2016https://conductscience.org/library/papers/26472207PubMed
25961003Biomarker identification and pathway analysis by serum metabolomics of lung cancer.Biomed Res Int2015https://conductscience.org/library/papers/25961003PubMed
25915662Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.Oncotarget2015https://conductscience.org/library/papers/25915662PubMed
25330231Critical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration.PLoS One2014https://conductscience.org/library/papers/25330231PubMed
24816639
Knockdown of sphingosine kinase 1 inhibits the migration and invasion of human rheumatoid arthritis fibroblast-like synoviocytes by down-regulating the PI3K/AKT activation and MMP-2/9 production in vitro.
Mol Biol Rep2014https://conductscience.org/library/papers/24816639PubMed
24768038Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.Mol Oncol2014https://conductscience.org/library/papers/24768038PubMed
24468113Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease.Acta Neuropathol Commun2014https://conductscience.org/library/papers/24468113PubMed

See all 29 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SPHK18877PubTator's text mininghttps://conductscience.org/library/genes/8877

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18620522

GET https://conductscience.org/api/papers/v1/18620522/cited_by?page=2